Glioblastoma stem cells: a therapeutic challenge

Authors

ERDOĞAN PEKCAN ERKAN
UFUK VURGUN
REŞAT SERHAT ERBAYRAKTAR
ZÜBEYDE ERBAYRAKTAR

DOI

10.3906/biy-1508-79

Abstract

The outcome for glioblastoma patients remains extremely poor, despite the advances in surgical and medical fields. It is hypothesized that glioblastoma progression, as well as tumor recurrence, is driven by a small number of cells called cancer stem cells (CSCs), which are characterized by their ability of self-renewal and proliferation, giving rise to progeny of transformation into multiple neuroepithelial lineages. Understanding the biology of CSCs is likely to explain why existing treatment strategies fail to affect the relatively quiescent and resistant CSC compartment. Here, we review the current knowledge on CSCs in glial tumors. In addition, we discuss the importance of the CSC hypothesis in the advancement of therapies for brain tumors.

Keywords

Glioblastoma, cancer stem cell, therapy, resistance

First Page

990

Last Page

997

Recommended Citation

ERKAN, ERDOĞAN PEKCAN; VURGUN, UFUK; ERBAYRAKTAR, REŞAT SERHAT; and ERBAYRAKTAR, ZÜBEYDE (2016) "Glioblastoma stem cells: a therapeutic challenge," Turkish Journal of Biology: Vol. 40: No. 5, Article 4. https://doi.org/10.3906/biy-1508-79
Available at: https://journals.tubitak.gov.tr/biology/vol40/iss5/4